| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.01 |
| mRNA |
TKI258 |
CCLE |
pan-cancer |
AAC |
-0.12 |
0.01 |
| mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |
| mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
-0.11 |
0.01 |
| mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.01 |
| mRNA |
JW-7-52-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.01 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.01 |
| mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.01 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.01 |